🇧🇷 Lymphostat B in Brazil

Lymphostat B (BELIMUMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Lymphostat B in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Lymphostat B approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Lymphostat B in Brazil?

Human Genome Sciences Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.